• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidinecarboxamides

Introduction to N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide (CAS No. 1489436-18-1)

N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide, a compound with the chemical identifier CAS No. 1489436-18-1, represents a significant advancement in the field of pharmaceutical chemistry. This compound belongs to a class of molecules that have garnered considerable attention due to their potential applications in drug development and biotechnology. The structural uniqueness of N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide lies in its pyrrolidine core, which is functionalized with a hydroxypropyl group and a carboxamide moiety. Such structural features not only contribute to its distinct chemical properties but also open up diverse possibilities for its utilization in medicinal chemistry.

The synthesis and characterization of N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide have been subjects of extensive research, with methodologies being refined to achieve high yields and purity. The hydroxypropyl group introduces a polar characteristic, enhancing the compound's solubility in aqueous solutions, which is a critical factor for its biological activity and pharmacokinetic behavior. This solubility profile makes it particularly suitable for formulation in drug delivery systems designed for oral or parenteral administration.

Recent studies have highlighted the pharmacological potential of derivatives of pyrrolidine-based compounds. The presence of the carboxamide group in N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide suggests possible interactions with biological targets such as enzymes and receptors, which are pivotal in modulating various physiological processes. Preliminary in vitro studies have indicated that this compound exhibits promising activities in certain biochemical pathways, making it a candidate for further investigation in therapeutic contexts.

The field of drug discovery has seen significant advancements due to the development of novel molecular entities like N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide. The integration of computational chemistry and high-throughput screening techniques has expedited the identification of compounds with desirable pharmacological properties. In this regard, N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide stands out as a compound whose structural attributes align well with the criteria for an effective pharmaceutical agent.

One of the most intriguing aspects of N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide is its potential role in modulating inflammation and immune responses. The pyrrolidine scaffold is known to be present in several bioactive molecules that have demonstrated efficacy in reducing inflammation-related pathologies. The hydroxypropyl group may contribute to the compound's ability to interact with inflammatory mediators, thereby offering a novel approach to treating chronic inflammatory conditions.

In addition to its anti-inflammatory potential, N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide has shown promise in preclinical models as a modulator of central nervous system (CNS) functions. The ability of this compound to cross the blood-brain barrier, facilitated by its hydrophilic nature, positions it as a candidate for treating neurological disorders. Current research is focused on elucidating its mechanisms of action within neural circuits, particularly in relation to neurotransmitter systems involved in mood regulation and cognitive processes.

The development of new synthetic routes for N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide has been a key focus area for synthetic chemists. Advances in green chemistry principles have enabled more sustainable and efficient synthesis methods, reducing waste and minimizing environmental impact. These innovations not only enhance the scalability of production but also align with global efforts towards sustainable pharmaceutical manufacturing.

The pharmacokinetic properties of N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide are another critical aspect that has been thoroughly investigated. Studies have revealed that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles, suggesting its potential for clinical translation. Understanding these properties is essential for optimizing dosing regimens and ensuring therapeutic efficacy while minimizing side effects.

The role of computational modeling in predicting the biological activity of N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide cannot be overstated. Advanced computational techniques such as molecular docking and quantum mechanical calculations have provided valuable insights into how this compound interacts with biological targets at the molecular level. These insights are crucial for guiding experimental design and accelerating the drug discovery process.

In conclusion, N-(3-Hydroxypropyl)pyrrolidine-1-carboxamide (CAS No. 1489436-18-1) represents a compelling example of how structural innovation can lead to the development of novel therapeutic agents. Its unique chemical properties, coupled with promising preclinical data, position it as a valuable candidate for further exploration in pharmaceutical research. As our understanding of biological systems continues to evolve, compounds like this are likely to play an increasingly important role in addressing complex diseases and improving patient outcomes.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)